New investors BGF have joined the round, which will fund an expanded US and EU clinical study of CroíValve's Duo Tricuspid Coaptation Valve System.
Read more: CroíValve adds $20m to Series B, taking round to $36m
June 24, 2026 - BY Silicon Republic